|
End-of-day quote
Korea S.E.
2026-09-14
|
5-day change | 1st Jan Change | ||
| 16,270.00 KRW | -3.56% |
|
-6.22% | -71.66% |
| 07-23 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 12-21 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
Transcripts
Search
No results match your criteria
- Stock Market
- Stocks
- A287840 Stock
- News IntoCell, Inc.
- Transcripts
Select your edition
All financial news and data tailored to specific country editions
